Delhi High Court Rules In Favour Of Natco Pharma In a Patent Dispute Case
- Natco Pharma which had won a patent dispute case against Novartis regarding usage and sale of generic version of Cancer treating drug in India has won yet another patent dispute case against Teva Pharmaceuticals of Israel.
- This case relates to marketing of generic version of Teva’s drug which treats multiple sclerosis.
- The decision will allow Natco to launch its drug in US subject to approval from U.S. Food & Drug Administration (USFDA).
- Patent Wars
- Generic Drugs
- Compulsory Licensing